Power Mobility Scooter (MA03)
Nanjing Mijo Technology Co., Ltd. · Decision date Sep 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-29 for Power Mobility Scooter (MA03), submitted by Nanjing Mijo Technology Co., Ltd. under 510(k) number K262213. The device falls under regulation 890.3800, product code INI, with the classification name Vehicle, Motorized 3-Wheeled, and Physical Medicine as both medical specialty and review panel. The application was received 06/30/2026 as a traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. SESE denotes clearance to market, not PMA approval.
The available summary excerpt describes the subject device as using a 24 V, 180 W motor, one 24 V, 10.4 Ah lithium-ion battery and an off-board charger, with anti-tip devices and a stated theoretical driving range of 10.1 km versus 16.3 km for the predicate device. The excerpt also references an 8° figure whose meaning is not established in the retrieved text. The predicate device is not identified in the available material, and no clinical or performance conclusions are drawn here; the full decision document should be consulted for scope and any conditions.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262213
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Nanjing Mijo Technology Co., Ltd.
- Product code
- INI
- Decision code
- SESE
- Decision date
- Sep 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Vehicle, Motorized 3-Wheeled.
- Applicant
- Nanjing Mijo Technology Co., Ltd.
- Product code
- INI
- FDA device class
- 2
FDA decision timeline
K262213 received
Application receipt date recorded by FDA.
K262213 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code INI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zhejiang Kailang Technology Co., Ltd. | 510(k) clearance | Sep 29, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Sep 24, 2026 | FDA | |
| Anhui JBH Medical Apparatus Co., Ltd. | 510(k) clearance | Sep 19, 2026 | FDA | |
| Zhejiang Innuovo Rehabilitation Devices Co.,Ltd | 510(k) clearance | Aug 10, 2026 | FDA | |
| Zhejiang Innuovo Rehabilitation Devices Co.,Ltd | 510(k) clearance | Aug 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Nanjing Mijo Technology Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Nanjing
Sources and methodology
- Original FDA record: K262213
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

